Hers generally follows FDA guidelines for GLP-1 eligibility: a BMI of 30 or higher, or 27+ with at least one weight-related condition (such as type 2 diabetes, high blood pressure, or sleep apnea)
Step 3: Prior Authorization and Medication Delivery After prescription, Klinic expertly handles prior authorizations and coordinates straightforward medication delivery
Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
The patterns are predictable, and preparation goes a long way
When Stomach Pain Signals a Need for Personalized Adjustment Persistent or severe stomach pain may indicate that your current semaglutide dose or delivery method doesn't align with your individual tolerance profile